KIORA PHARMACEUTICALS, INC. Shares Issued
KIORA PHARMACEUTICALS, INC. (KPRX) had Shares Issued of 4.43 million shares as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-07
- 2026-06-30: Common Stock, Shares, Issued 4.43M shares.
- 2026-03-31: Common Stock, Shares, Issued 3.99M shares.
- 2025-12-31: Common Stock, Shares, Issued 3.76M shares.
- 2025-09-30: Common Stock, Shares, Issued 3.43M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 4.43M shares 10-Q · filed 2026-08-07 | |
| 2026-03-31 | 3.99M shares 10-Q · filed 2026-05-08 | |
| 2025-12-31 | 3.76M shares 10-Q · filed 2026-08-07 | |
| 2025-09-30 | 3.43M shares 10-Q · filed 2025-11-07 | |
| 2025-06-30 | 3.43M shares 10-Q · filed 2025-08-08 | |
| 2025-03-31 | 3.00M shares 10-Q · filed 2025-05-09 | |
| 2024-12-31 | 3.00M shares 10-K · filed 2026-03-25 | |
| 2024-09-30 | 3.00M shares 10-Q · filed 2024-11-08 | |
| 2024-06-30 | 2.97M shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 26.26M shares 10-Q · filed 2024-05-10 | |
| 2023-12-31 | 856.18K shares 10-K · filed 2025-03-25 | 7.71M shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 7.69M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 6.91M shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 1.92M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 1.80M shares 10-K · filed 2024-03-25 | |
| 2022-09-30 | 1.08M shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 13.07M shares 10-Q · filed 2022-08-12 | |
| 2022-03-31 | 12.66M shares 10-Q · filed 2022-07-08 | |
| 2021-12-31 | 316.60K shares 10-K · filed 2023-03-23 | 12.66M shares 10-K · filed 2022-04-15 |
| 2021-09-30 | 12.62M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 7.10M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 7.10M shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 5.56M shares 10-K/A · filed 2022-07-07 | |
| 2020-09-30 | 4.63M shares 10-Q · filed 2020-11-09 | |
| 2020-06-30 | 4.63M shares 10-Q · filed 2020-08-06 | |
| 2020-03-31 | 4.63M shares 10-Q · filed 2020-05-06 | |
| 2019-12-31 | 4.08M shares 10-K · filed 2021-03-25 | |
| 2019-09-30 | 3.04M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 45.68M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 45.58M shares 10-Q · filed 2019-05-08 | |
| 2018-12-31 | 3.04M shares 10-K · filed 2020-03-04 | 43.79M shares 10-K · filed 2019-03-01 |
| 2018-09-30 | 43.44M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 42.38M shares 10-Q · filed 2018-08-03 | |
| 2018-03-31 | 17.26M shares 10-Q · filed 2018-05-11 | |
| 2017-12-31 | 17.26M shares 10-K · filed 2019-03-01 | |
| 2017-09-30 | 17.20M shares 10-Q · filed 2017-11-14 | |
| 2017-06-30 | 17.20M shares 10-Q · filed 2017-08-04 | |
| 2017-03-31 | 10.88M shares 10-Q · filed 2017-05-05 | |
| 2016-12-31 | 10.13M shares 10-K · filed 2018-03-02 | |
| 2016-09-30 | 9.59M shares 10-Q · filed 2016-11-01 | |
| 2016-06-30 | 8.95M shares 10-Q · filed 2016-08-10 | |
| 2016-03-31 | 8.35M shares 10-Q · filed 2016-05-13 | |
| 2015-12-31 | 7.66M shares 10-K · filed 2017-02-23 | |
| 2015-09-30 | 7.65M shares 10-Q · filed 2015-11-12 | |
| 2015-06-30 | 6.48M shares 10-Q · filed 2015-08-12 | |
| 2015-03-31 | 6.35M shares 10-Q · filed 2015-05-18 | |
| 2014-12-31 | 201.79K shares 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |